DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Rebif (Interferon Beta-1a) - Current Clinical Trials

 
 



Rebif Related Clinical Trials

Supplementation of VigantOL� Oil Versus Placebo as Add-on in Patients With Relapsing Remitting Multiple Sclerosis Receiving Rebif� Treatment [Completed]

Post Marketing Surveillance Study to Evaluate the Tolerability of Rebif� New Formulation in Patients With Relapsing Multiple Sclerosis in an Australian Clinical Setting. [Completed]

An Observational Study to Document the Effectiveness and Compatibility of Rebif 44 or 22 µg in the Therapy of the Chronic Multiple Sclerosis [Completed]

Post-Authorization Observational Study to Evaluate Cognition and Fatigue in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Treated With Rebif [Completed]

Retrospective Cohort Study of Rebif Use in Pediatric Multiple Sclerosis (MS) Subjects (REPLAY) [Completed]

A Pilot Trial of Interferon Beta-1a in Alzheimer's Disease [Completed]

A Study of Rebif in Subjects With Relapsing Multiple Sclerosis [Recruiting]

A Study of Rebif Compared With Avonex in the Treatment of Relapsing-remitting Multiple Sclerosis (MS) [Completed]

Study to Determine if Avonex and Rebif Work Comparably Well in Subjects With Relapsing Multiple Sclerosis [Completed]

Open Label Study of Tolerability, PK and PD of BCD-054 (Pegylated Interferon Beta-1a), IM and SC, Compared to Rebif and Avonex in Healthy Volunteers [Active, not recruiting]

A Phase IV Study of Rebif 44mcg Administered Three Times Per Week by Subcutaneous Injection Compared With no Treatment in the Therapy of Relapsing Multiple Sclerosis After Mitoxantrone [Completed]

Tolerability of Rebif (Interferon-beta 1-A) Therapy in Korean Patients With Multiple Sclerosis [Completed]

Study To Evaluate The Immunogenicity And Safety Of r-hIFN Beta-1a (Rebif) Using Clone 484-39 In Multiple Sclerosis [Completed]

A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Patients With Relapsing Multiple Sclerosis [Active, not recruiting]

A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Patients With Relapsing Multiple Sclerosis [Active, not recruiting]

A Bioequivalence Study of Serum Free Avonex and Serum Containing Avonex in Healthy Volunteers [Completed]

A Multiple Dose Safety Study of PEG-IFN in Healthy Volunteers [Completed]

An Observational Study for the Assessment of Compliance and Persistence to Rebif� Therapy of Patients With Relapsing-remitting Multiple Sclerosis (MS) and Evaluation of Potential Factors Influencing These Parameters [Completed]

Randomized Study Designed to Look at Disease Progression Using 2 Currently FDA Approved Drugs for the Treatment of RRMS [Terminated]

The Neuroprotective Effect of Lamotrigine and Interferon Beta 1a in Patients With Relapsing-Remitting Multiple Sclerosis [Recruiting]

Aerobic Exercise and Flu-like Symptoms Following Interferon Beta 1a Injections in Patients With Multiple Sclerosis? [Active, not recruiting]

Long-term Follow-Up of Patients Who Participated in Study 27025 (REFLEX) [Completed]

Adherence Trial With MS LifeLines Services [Terminated]

Safety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple Sclerosis [Completed]

Safety Study of Combination Therapy With Intramuscular Avonex and Oral Cellcept in Patients With Multiple Sclerosis [Completed]

An Observational Study to Evaluate Quality of Life (QoL) and Influence of Cognitive Status on QoL in Patients With Relapsing-Remitting Multiple Sclerosis (RRMS) During 2 Years Treatment With Rebif New Formulation (RNF) [Completed]

Phase 3 Efficacy and Safety Study of BG00012 in Pediatric Subjects With Relapsing-remitting Multiple Sclerosis (RRMS) [Recruiting]

Efficacy and Safety Study of Peginterferon Beta-1a in Participants With Relapsing Multiple Sclerosis [Completed]

A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis [Active, not recruiting]

Evaluation of Emotional Disorders During Treatment by Interferon Beta in Relapsing-remitting Multiple Sclerosis Patients [Completed]

Canadian Avonex PEN Productivity Study [Completed]

The Multicenter, Open-label, Single-use Autoinjector Convenience Study [Completed]

Clinical 15 Months Study Comparing Monthly Pulse ACTH (Acthar Gel) Therapy With Monthly Methylprednisolone (MP, Solumedrol) for Multiple Sclerosis (MS) Patients Who Are on Regular Beta-interferons (Avonex, Betaseron or Rebif) [Active, not recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015